Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
A phase 1/2 trial of [203Pb]VMT-α-NET in neuroendocrine tumours, pancreatic ductal adenocarcinoma and pheochromocytoma and paraganglioma, run by Perspective Therapeutics, now recruiting.
Overview
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors is a phase 1/2 interventional study registered as NCT05636618 by Perspective Therapeutics, with 300 participants planned, started 2023-09-27 and due to reach its primary completion in 2029-11-26. Interventions recorded: [203Pb]VMT-α-NET and [212Pb]VMT-α-NET.
Similar pages
not linked directly; found by shared links- TrialStudy of CVM-1118 for Patients With Advanced Neuroendocrine Tumors
Shares Neuroendocrine tumours, Pancreatic ductal adenocarcinoma and the tag pipeline.
- TrialLead-212 PSV359 Therapy for Patients With Solid Tumors
Shares Perspective Therapeutics, Pancreatic ductal adenocarcinoma and the tag pipeline.
- TrialCarcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Shares Neuroendocrine tumours, Pancreatic ductal adenocarcinoma and the tag pipeline.
- TrialStudy of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
Shares Pheochromocytoma and paraganglioma (PPGL) and the tag pipeline.
- TrialDose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Shares Neuroendocrine tumours and the tag pipeline.
- TrialStudy of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
Shares Neuroendocrine tumours, Pancreatic ductal adenocarcinoma and the tag pipeline.
- TrialGlufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Shares Pancreatic ductal adenocarcinoma and the tag pipeline.
- TrialA Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer
Shares Pancreatic ductal adenocarcinoma and the tag pipeline.